Literature DB >> 2676019

Inhibition of malarial parasite invasion by monoclonal antibodies against glycophorin A correlates with reduction in red cell membrane deformability.

G Pasvol1, J A Chasis, N Mohandas, D J Anstee, M J Tanner, A H Merry.   

Abstract

The effect of well-characterized monoclonal antibodies to red cell surface molecules on the invasion of human red cells by the malarial parasites Plasmodium falciparum and Plasmodium knowlesi was examined. Antibodies to glycophorin A (GP alpha) inhibit invasion for both parasite species, and this is highly correlated with the degree to which they decrease red cell membrane deformability as measured by ektacytometry. This effect on rigidity and invasion was also seen with monovalent Fab fragments. The closer the antibody binding site was to the membrane bilayer, the greater was its effect on inducing membrane rigidity and decreasing parasite invasion. Antibodies to the Wright determinant in particular were the most inhibitory. This differential effect of the various antibodies was not correlated with their binding affinities or the number of sites bound per cell. Antibodies to surface molecules other than GP alpha were without effect. A novel mechanism is described whereby monoclonal antibodies and their Fab fragments directed at determinants on the external surface of red cells might act to inhibit invasion by malarial parasites by altering membrane material properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2676019

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Functional analysis of erythrocyte determinants of Plasmodium infection.

Authors:  Amy K Bei; Manoj T Duraisingh
Journal:  Int J Parasitol       Date:  2012-04-19       Impact factor: 3.981

2.  Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis.

Authors:  P Jarolim; J Palek; D Amato; K Hassan; P Sapak; G T Nurse; H L Rubin; S Zhai; K E Sahr; S C Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.

Authors:  Carlos H Villa; Daniel C Pan; Ian H Johnston; Colin F Greineder; Landis R Walsh; Elizabeth D Hood; Douglas B Cines; Mortimer Poncz; Don L Siegel; Vladimir R Muzykantov
Journal:  Blood Adv       Date:  2018-02-13

Review 4.  Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.

Authors:  Carlos H Villa; Douglas B Cines; Don L Siegel; Vladimir Muzykantov
Journal:  Transfus Med Rev       Date:  2016-08-17

5.  Loss of rotational mobility of band 3 proteins in human erythrocyte membranes induced by antibodies to glycophorin A.

Authors:  A Che; R J Cherry
Journal:  Biophys J       Date:  1995-05       Impact factor: 4.033

6.  Membrane skeleton restraint of surface shape change during fusion of erythrocyte membranes: evidence from use of osmotic and dielectrophoretic microforces as probes.

Authors:  A E Sowers
Journal:  Biophys J       Date:  1995-12       Impact factor: 4.033

7.  In vitro genetic analysis of an erythrocyte determinant of malaria infection.

Authors:  Amy K Bei; Carlo Brugnara; Manoj T Duraisingh
Journal:  J Infect Dis       Date:  2010-10-19       Impact factor: 5.226

8.  Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions.

Authors:  B S Coller; K T Springer; J H Beer; N Mohandas; L E Scudder; K J Norton; S M West
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

Review 9.  Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems.

Authors:  Carlos H Villa; Aaron C Anselmo; Samir Mitragotri; Vladimir Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2016-03-03       Impact factor: 15.470

10.  Identification of binding domains on red blood cell glycophorins for Babesia divergens.

Authors:  Jeny R Cursino-Santos; Greg Halverson; Marilis Rodriguez; Mohandas Narla; Cheryl A Lobo
Journal:  Transfusion       Date:  2013-08-14       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.